2-(4-chlorobenzoyl)hydrazinecarboximidamide | 51884-13-0

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 英文名称: 2-(4-chlorobenzoyl)hydrazinecarboximidamide
• 英文别名: N-(4-chlorobenzamido)-guanidine；N-Amidino-(p-chlor)benzohydrazid；4-Chlor-benzamino-guanidin；(4-chloro-benzoylamino)-guanidine；4-Chlorobenzoic acid 2-amidinohydrazide；(4-Chlor-benzoylamino)-guanidin；4-chloro-N-(diaminomethylideneamino)benzamide
• CAS: 51884-13-0
• 化学式: C₈H₉ClN₄O
• 分子量: 212.639
• InChiKey: YWPGDIMQGIWSKK-UHFFFAOYSA-N

物化性质

• 熔点：
  194-196 °C(Solv: ethanol (64-17-5))
• 密度：
  1.49±0.1 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  0.6
• 重原子数：
  14
• 可旋转键数：
  2
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.0
• 拓扑面积：
  93.5
• 氢给体数：
  3
• 氢受体数：
  2

反应信息

• 作为反应物：
  描述：

  2-(4-chlorobenzoyl)hydrazinecarboximidamide 以 N,N-二甲基甲酰胺 为溶剂， 反应 60.0h， 生成 5-氨基-3-(4-氯苯基)-N-甲基-1,2,4-三唑-1-硫代甲酰胺
  参考文献：
  名称：

  Synthesis and Pharmacological Activity of Triazole Derivatives Inhibiting Eosinophilia

  摘要：

  In order to develop novel antiasthmatic agents based on a new mechanism of action, a series of 3-substituted 5-amino-1-[(methylamino)(thiocarbonyl)]-1H-1,2,4-triazole derivatives were synthesized and evaluated in a model in which eosinophilia was induced in the ah-way through intravenous (iv) injection of Sephadex particles on days 0, 2, and 5. After screening of several hundred derivatives, we finally identified the highly potent eosinophilia inhibitor 5-amino-3-(4-chlorophenyl)-1-[(methylamino)(thiocarbonyl)]-1H-triazole (23c, GCC-AP0341), which had ID50 values of 0.3 and 0.07 mg/kg when administered orally (os) and intraperitoneally tip), respectively. This compound showed complete inhibition of the hypersensitivity induced by ascaris inhalation at an ip dose of 1 mg/kg as well as low toxicity, with an LD(50) value of > 2.0 g/kg in mice. Extensive study of its mechanism of action revealed that 23c inhibited eosinophil survival induced by interleukin-5 (IL-5), but had little or no effect on leukotriene D-4 (LTD(4)) or platelet-activating factor (PAF)-induced responses. Taken together, these results suggest 23e as a novel candidate for the treatment of chronic asthma. Further studies are now underway.

  DOI：

  10.1021/jm9507993
• 作为产物：
  描述：

  4-氯苯甲酰氯 在 一水合肼 、 sodium hydroxide 作用下， 以 1,4-二氧六环 、 二氯甲烷 为溶剂， 生成 2-(4-chlorobenzoyl)hydrazinecarboximidamide
  参考文献：
  名称：

  Design, synthesis and pharmacological evaluation of tricyclic derivatives as selective RXFP4 agonists

  摘要：

  DOI：

  10.1016/j.bioorg.2021.104782

文献信息

• [EN] HETEROCYCLIC COMPOUNDS FOR THE INHIBITION OF PASK<br/>[FR] COMPOSÉS HÉTÉROCYCLIQUES POUR L'INHIBITION DE PASK
  申请人：BIOENERGENIX

  公开号：WO2014066743A1

  公开（公告）日：2014-05-01

  Disclosed herein are new heterocyclic compounds and compositions and their application as pharmaceuticals for the treatment of disease. Methods of inhibiting PAS Kinase (PASK) activity in a human or animal subject are also provided for the treatment of diseases such as diabetes mellitus.

  本文披露了新的杂环化合物和组合物，以及它们作为药物治疗疾病的应用。还提供了抑制PAS激酶（PASK）在人类或动物主体中活性的方法，用于治疗疾病，如糖尿病。
• Synthesis, anticancer activity and molecular modeling studies of 1,2,4-triazole derivatives as EGFR inhibitors
  作者：Hany A.M. El-Sherief、Bahaa G.M. Youssif、Syed Nasir Abbas Bukhari、Ahmed H. Abdelazeem、Mohamed Abdel-Aziz、Hamdy M. Abdel-Rahman

  DOI：10.1016/j.ejmech.2018.07.024

  日期：2018.8

  and evaluated for their antiproliferative activities against NCI 60 cell line. Compounds 10 (a, c), 11 (a-d), and 14 (a-e) were selected for evaluation at single concentration of 10 μM towards panel of sixty cancer cell lines. Some of nitric oxide (NO) donating triazole/oxime hybrids 11a-d showed antiproliferative activity better than their corresponding ketones. On the other hand, the thiazolo [3,2-b][1

  制备了一系列带有1,2,4-三唑支架的新型化合物，并评估了它们对NCI 60细胞系的抗增殖活性。选择化合物10（a，c），11（ad）和14（ae）以单一浓度10μM对六十个癌细胞系进行评估。一氧化氮（NO）捐赠的三唑/肟杂化物11a-d显示出比其相应的酮更好的抗增殖活性。另一方面，噻唑洛[3,2-b] [1,2,4]-三唑14a-e对相同的细胞系表现出显着的抗增殖活性。选择化合物14d以针对60种人类肿瘤细胞系的整个组进行五次剂量测试。化合物14d在GI 50水平下显示出对肾亚板的高选择性，选择性比为6.99 。使用MTT测定法针对四种细胞系测试化合物11a-d，10a-d和14a-e，然后针对三种已知的抗癌靶标（包括EGFR，BRAF和微管蛋白）评估IC 50最小的化合物。结果表明，化合物14d显示出对癌细胞增殖的有希望的EGFR抑制活性，并且还被观察到是中等的BRAF和微管蛋白抑制剂
• Tautomerism and basicity of carboxylic acid guanyl hydrazides (acylaminoguanidines)
  作者：A. V. Astakhov、E. V. Tarasova、A. V. Chernysheva、V. B. Rybakov、Z. A. Starikova、V. M. Chernyshev

  DOI：10.1007/s11172-021-3246-8

  日期：2021.8

  acid-base properties, structures, and tautomerism of protonated and free forms of carboxylic acid guanyl hydrazides (acylaminoguanidines) were studied using experimental and theoretical methods. According to the experimental data, guanyl hydrazides are relatively strong bases (pKa 8.1-8.9 in water at 25 °C) in spite of the presence of the electron-withdrawing carbonyl group in their molecules. The results

  使用实验和理论方法研究了质子化和游离形式的羧酸脒酰肼（酰基氨基胍）的酸碱性质、结构和互变异构现象。根据实验数据，尽管分子中存在吸电子羰基，但胍基酰肼是相对强的碱（在 25°C 的水中p K a 8.1-8.9）。NMR光谱、X射线衍射分析和DFT计算的研究结果表明，在极性介质中，游离的胍基酰肼主要以两性离子互变异构体（内盐）的形式存在，正电荷定位在质子化胍部分，负电荷定位在去质子化胍部分。酰胺基。
• 3-Aryl/Heteroaryl-5-amino-1-(3′,4′,5′-trimethoxybenzoyl)-1,2,4-triazoles as antimicrotubule agents. Design, synthesis, antiproliferative activity and inhibition of tubulin polymerization
  作者：Romeo Romagnoli、Filippo Prencipe、Paola Oliva、Stefania Baraldi、Pier Giovanni Baraldi、Andrea Brancale、Salvatore Ferla、Ernest Hamel、Roberta Bortolozzi、Giampietro Viola

  DOI：10.1016/j.bioorg.2018.06.037

  日期：2018.10

  at the 3-position of the 5-amino-1,2,4-triazole system. Most of the twenty-two tested compounds showed moderate to potent antiproliferative activities against a panel of solid tumor and leukemic cell lines, with four (5j, 5k, 5o and 5p) showing strong antiproliferative activity (IC50 < 1 μM) against selected cancer cells. Among them, several molecules preferentially inhibited the proliferation of leukemic

  已知许多天然和合成物质会干扰微管蛋白的动态组装，从而阻止微管的形成。在我们寻找有效的和选择性的抗肿瘤剂中，合成了一系列新的1-（3'，4'，5'-三甲氧基苯甲酰基）-5-氨基-1,2,4-三唑。这些化合物具有不同的杂环，包括噻吩，呋喃或三个同分异构的吡啶，并且它们在5-氨基-1,2,4-三唑体系的3位上具有带电子释放或吸电子取代基的苯环。 。测试的22种化合物中的大多数对一组实体瘤和白血病细胞系均显示出中度至强效的抗增殖活性，其中4种（5j，5k，5o和5p） 对选定的癌细胞显示出强大的抗增殖活性（IC 50 <1μM）。其中，有几种分子优先抑制白血病细胞系的增殖，显示Jurkat和RS4; 11细胞的IC 50值比源自实体瘤的三系（HeLa，HT-29和MCF- 7个单元格）。化合物5k强烈抑制微管蛋白组装，IC 50值为0.66μM，是在CA-4的同时实验中获得的一半（IC 50  =
• Synthesis and structure activity relationship investigation of triazolo[1,5-a]pyrimidines as CB2 cannabinoid receptor inverse agonists
  作者：Mojgan Aghazadeh Tabrizi、Pier Giovanni Baraldi、Emanuela Ruggiero、Giulia Saponaro、Stefania Baraldi、Giulio Poli、Tiziano Tuccinardi、Annalisa Ravani、Fabrizio Vincenzi、Pier Andrea Borea、Katia Varani

  DOI：10.1016/j.ejmech.2016.02.032

  日期：2016.5

  cannabinoid receptor ligands are known to be therapeutically important for the treatment of numerous diseases. Recently, we have identified the heteroaryl-4-oxopyridine/7-oxopyrimidine derivatives as highly potent and selective CB2 receptor ligands, showing that the pharmakodynamics of the new compounds was controlled by the nature of the heterocycle core. In this paper we describe the synthesis and biological

  已知CB 2大麻素受体配体对于多种疾病的治疗具有重要的治疗意义。最近，我们已经鉴定出杂芳基-4-氧代吡啶/ 7-氧嘧啶衍生物是高效且选择性的CB 2受体配体，表明新化合物的药效动力学受杂环核心性质的控制。在本文中，我们描述了7-氧代-4-戊基-4,7-二氢-[1,2,4]三唑并[1,5 - a ]嘧啶-6-羧酰胺衍生物的合成及生物学评价。新型CB 2受体反向激动剂的鉴定。CB 2上的循环AMP实验在CHO细胞中表达的受体显示三唑并嘧啶模板第2位的结构修饰的引入将功能活性从部分激动变为反向激动。报道了新型结构的分子对接分析。